RFCA
BSX icon

R&F Capital Advisors’s Boston Scientific BSX Stock Holding History

R&F Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.48M Sell
59,348
-18,154
-23% -$441K 0.38% 51
2016
Q4 		$1.68M Buy
+77,502
New +$1.69M 0.59% 31

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

R&F Capital Advisors's BSX Position: Q1 2017 in Review

R&F Capital Advisors reduced its Boston Scientific (BSX) stake by 23% in Q1 2017, selling an estimated $441K and leaving 59,348 shares worth $1.48M. The position accounts for 0.38% of the portfolio, ranked #51.

R&F Capital Advisors first reported a position in BSX in Q4 2016 and has held it in 2 quarters since. The position peaked at $1.68M in Q4 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • R&F Capital Advisors held 59,348 shares of Boston Scientific worth $1.48M as of Q1 2017.
  • R&F Capital Advisors sold 18,154 Boston Scientific shares in Q1 2017, an estimated $441K.
  • Boston Scientific made up 0.38% of R&F Capital Advisors's portfolio in Q1 2017, its #51 holding.
  • R&F Capital Advisors first reported a position in Boston Scientific in Q4 2016 and has held it in 2 quarters since.
  • R&F Capital Advisors's Boston Scientific position peaked at $1.68M in Q4 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.